Vivax Malaria: Clinical Trials

3 trials for Vivax Malaria, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 withdrawn. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Not yet recruiting 1, Withdrawn 1

Follow Vivax Malaria: new trials by email Literature Review of Vivax Malaria trials Research Report on Vivax Malaria

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tafenoquine Drug Levels in Small Children
Chloroquine, Tafenoquine - Plasmodium Vivax Malaria, Vivax Malaria
Phase 2Not yet recruitingUniversity of Oxford202026-09-012026-09-22
Safety and Efficacy of Different Regimens of Primaquine on Vivax Malaria Treatment in G6PD Deficient Patients
Chloroquine, Primaquine - Vivax Malaria, G6PD Deficiency
Phase 2CompletedFundação de Medicina Tropical Dr. Heitor Vieira Dourado1062018-07-202025-02-20
Methylene Blue Against Vivax Malaria in Ethiopia
Artemeter-Lumefantrine and MB (combination therapy), Artemeter-Lumefantrine (combination therapy), Artemeter-Lumefantrine and Primaquine (combination therapy) - Vivax Malaria
Phase 2WithdrawnHeidelberg University2016-04-012020-03-25

Narrower conditions

Malaria, Vivax (3)  ·  Glucosephosphate Dehydrogenase Deficiency (1)

Broader conditions

Infections (3)  ·  Malaria (3)  ·  Mosquito-Borne Diseases (3)  ·  Parasitic Diseases (3)  ·  Protozoan Infections (3)  ·  Vector Borne Diseases (3)  ·  Anemia (1)  ·  Anemia, Hemolytic (1)  ·  Anemia, Hemolytic, Congenital (1)  ·  Carbohydrate Metabolism, Inborn Errors (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Metabolic Diseases (1)

Interventions

Chloroquine (2)  ·  Primaquine (2)  ·  3,7-bis(diethylamino)phenothiazin-5-ium (1)  ·  Combined Modality Therapy (1)  ·  tafenoquine (1)

Sponsors

Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (1)  ·  Heidelberg University (1)  ·  University of Oxford (1)

Countries

Brazil (1)  ·  Thailand (1)  ·  Vietnam (1)

Top investigators

Cindy Chu, MD, PhD (1)  ·  Marcus VG Lacerda, MD, PhD (1)

Results publications

PMID 39785834

NIH funding

U01AI195203 (1)